Impact of key prognostic factors on long-term overall survival in BRAF(V600)-mutated metastatic melanoma patients treated with vemurafenib in the BRIM-3 study Meeting Abstract
| Authors: | Hauschild, A.; Chapman, P. B.; Robert, C.; Larkin, J.; Haanen, J. B.; Ribas, A.; Hogg, D.; Hamid, O.; Ascierto, P. A.; Testori, A.; Lorigan, P.; Dummer, R.; Sosman, J. A.; Flaherty, K. T.; Wongchenko, M. J.; Yan, Y.; Chang, I.; Coleman, S.; Caro, I.; McArthur, G. A. |
| Abstract Title: | Impact of key prognostic factors on long-term overall survival in BRAF(V600)-mutated metastatic melanoma patients treated with vemurafenib in the BRIM-3 study |
| Meeting Title: | 16th World Congress on Cancers of the Skin (WCCS) |
| Journal Title: | Melanoma Research |
| Volume: | 26 |
| Issue: | e-Suppl. |
| Meeting Dates: | 2016 Aug 31-Sep 3 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0960-8931 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2016-08-01 |
| Start Page: | e39 |
| End Page: | e40 |
| Language: | English |
| ACCESSION: | WOS:000383560800075 |
| PROVIDER: | wos |
| DOI: | 10.1097/CMR.0000000000000285 |
| Notes: | Meeting Abstract: P057 -- Source: Wos |
